CYP19A1 and androgen insensitivity syndrome: Analogous findings are seen clinically as patients with either aromatase deficiency, ERα deficiency, or androgen insensitivity syndrome, have osteopenic skeletons, suggesting a need for both androgen and estrogen receptor signaling for maintenance of bone density.